Curing hepatocellular carcinomatosis with biologic therapy and surgery: Achieving the impossible?
Year: 2007
Type: article
Study design: Case Report
Abstract: Hepatocellular carcinoma (HCC) that present as hemoperitoneum are uncommon, often recur as peritoneal carcinomatosis, and have poor prognosis. Systemic chemotherapies are minimally effective in advanced HCC and less so as neo-adjuvant therapy. This report describes a 47-year woman with ruptured HCC who developed recurrent carcinomatosis. She received biologically targeted systemic therapy which resulted in significant radiographic tumor response. Salvage surgery revealed complete pathologic response in all tumor nodules, thus the patient was rendered cancer-free.
Source: Journal of Surgical Oncology
DOI: 10.1002/jso.20898
Institution: The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2013838666